What is the first-line treatment regimen for Helicobacter pylori infection in an adult without drug allergies or prior therapy?

First-Line Treatment of H. Pylori Infection

For treatment-naive adults without drug allergies, bismuth quadruple therapy (BQT) for 14 days is the preferred first-line regimen when antibiotic susceptibility is unknown. 1

Recommended First-Line Regimens

The choice of first-line therapy depends primarily on local antibiotic resistance patterns and bismuth availability:

Bismuth Quadruple Therapy (Preferred)

This is the most universally recommended first-line option across all major guidelines. 2, 1, 3

• Regimen components: PPI (twice daily) + bismuth (4 times daily) + metronidazole 500 mg (3-4 times daily) + tetracycline 500 mg (4 times daily) 2, 4
• Duration: 14 days 2, 1, 3
• Key advantage: Effective even in areas with high dual resistance to clarithromycin and metronidazole 2
• Important note: BQT maintains acceptable success rates even with in vitro metronidazole resistance 2

Alternative First-Line Options

When bismuth is unavailable or in specific resistance scenarios:

Concomitant Non-Bismuth Quadruple Therapy (PAMC):

• PPI (twice daily) + amoxicillin 1000 mg (twice daily) + metronidazole 500 mg (twice daily) + clarithromycin 500 mg (twice daily) 2
• Duration: 14 days 2, 3
• Appropriate for areas of high clarithromycin resistance where bismuth is unavailable 2

Rifabutin Triple Therapy:

• Rifabutin 150 mg (twice daily) + amoxicillin 1 g (three times daily) + high-dose PPI (40 mg esomeprazole or rabeprazole twice daily) 4, 1
• Duration: 14 days 4, 1
• Suitable empiric alternative in patients without penicillin allergy 1
• Theoretical advantage: resistance to rifabutin is rare 4

Restricted First-Line Therapy

PPI Triple Therapy (clarithromycin-based) should only be used in areas with documented low clarithromycin resistance (<15%). 2, 3, 5

• This regimen is no longer appropriate for empiric use in most regions due to increasing clarithromycin resistance 2, 3
• All three major consensus groups (Toronto, Maastricht V/Florence, and ACG) restrict this option 2

Critical Treatment Principles

Duration

All first-line regimens must be given for 14 days. 2, 1, 3

• The Toronto Consensus strongly recommends 14 days based on evidence of higher success versus shorter durations 2, 3
• The rationale: succeeding on the first attempt avoids retreating, retesting, reduces cost and anxiety, and minimizes negative impacts on gut microbiota 2

PPI Dosing

Use high-dose PPIs: minimum 40 mg omeprazole equivalent twice daily (or 20 mg rabeprazole/esomeprazole twice daily). 4

• Adequate acid suppression is essential for antibiotic efficacy 4, 5

Common Pitfalls to Avoid

• Do not use levofloxacin as first-line therapy in most patients—all guidelines agree it should be reserved for rescue therapy 2
• Avoid sequential and hybrid therapies—these are now considered obsolete as they include antibiotics offering no therapeutic benefit while increasing global antimicrobial resistance 4
• Do not substitute doxycycline for tetracycline in BQT—results are significantly inferior 4
• Avoid 10-day regimens unless locally proven equivalent to 14-day therapy 2

Practical Considerations

The best approach is to succeed on the first treatment attempt, which requires selecting the most effective regimen based on local resistance patterns rather than convenience 2, 3. When antibiotic susceptibility data are unavailable (the usual scenario), choose between BQT, concomitant therapy, or rifabutin triple therapy based on previous antibiotic exposure history and known local resistance prevalence 2.